Table 3.
Success rates (%) after Ahmed glaucoma valve implantation in the 2 groups for total participants and subgroups according to extent of peripheral anterior synechiae.
| Total (n = 70 eyes) | IVB group | Control | P value |
|
| |||
| PO 1 year | 80 (36/45) | 64 (16/25) | 0.142 |
| Final visits | 78 (35/45) | 56 (14/25) | 0.057 |
|
| |||
| PAS less than 50% (n = 46 eyes) | IVB group | Control | P value |
|
| |||
| PO 1 year | 89 (31/35) | 64 (7/11) | 0.057 |
| Final visits | 86 (30/35) | 64 (7/11) | 0.107 |
|
| |||
| PAS more than 50% (n = 24 eyes) | IVB group | Control | P value |
|
| |||
| PO 1 year | 50 (5/10) | 64 (9/14) | 0.678 |
| Final visits | 50 (5/10) | 50 (7/14) | 1.000 |
IVB = intravitreal bevacizumab; PO = postoperative; PAS = peripheral anterior synechiae.